Brief: Kingworld Medicines Group Says Substantial Shareholder To Transfer 15% Stake In Dong Di Xin To Plaintiff
02/08/2019 12:13
Aug 2 (Reuters) - Kingworld Medicines Group Ltd 1110.HK :
* BASED ON JUDGMENT FOR RE-TRIAL DATED 19 JUNE SUBSTANTIAL
SHAREHOLDER TO TRANSFER 15% STAKE IN DONG DI XIN TO PLAINTIFF
Source text for Eikon: ID:nHKS7WCsjJ
Further company coverage: 1110.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kingworld Medicines
See all newsBrief: Kingworld Medicines Group Says Unit Terminates MoU For Proposed Acquisition
Brief: Kingworld Medicines Expects To Record A Decrease In Profit Attributable By 70% To 75% For Year
Brief: Kingworld Medicines's Unit Entered Into MoU With Intended Vendor, Others
Brief: Kingworld Medicines Sees Decrease In HY Profit By 70%
Brief: Kingworld Medicines Sees Increase In Profit Attributable By 65% To 75% For Year